Anna K. Blakney

4.4k total citations · 1 hit paper
62 papers, 3.2k citations indexed

About

Anna K. Blakney is a scholar working on Molecular Biology, Immunology and Biomaterials. According to data from OpenAlex, Anna K. Blakney has authored 62 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 18 papers in Immunology and 11 papers in Biomaterials. Recurrent topics in Anna K. Blakney's work include RNA Interference and Gene Delivery (33 papers), Advanced biosensing and bioanalysis techniques (18 papers) and Immunotherapy and Immune Responses (13 papers). Anna K. Blakney is often cited by papers focused on RNA Interference and Gene Delivery (33 papers), Advanced biosensing and bioanalysis techniques (18 papers) and Immunotherapy and Immune Responses (13 papers). Anna K. Blakney collaborates with scholars based in United Kingdom, United States and Canada. Anna K. Blakney's co-authors include Stephanie J. Bryant, Robin J. Shattock, Paul F. McKay, Kim A. Woodrow, Karnyart Samnuan, Themis R. Kyriakides, Andrew J. Geall, Shell Ip, Clément R. Bouton and Kai Hu and has published in prestigious journals such as Nature, Cell and Advanced Materials.

In The Last Decade

Anna K. Blakney

60 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The advent of clinical self-amplifying RNA vaccines

2025 12 citations Anna K. Blakney et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna K. Blakney United Kingdom	31	1.6k	708	640	618	530	62	3.2k
Ana Jaklenec United States	25	1.8k 1.1×	400 0.6×	779 1.2×	1.2k 1.9×	713 1.3×	52	3.9k
Mohamad‐Gabriel Alameh United States	35	3.2k 2.0×	775 1.1×	952 1.5×	511 0.8×	429 0.8×	86	4.4k
Takashi Nakamura Japan	32	1.8k 1.2×	282 0.4×	1.5k 2.3×	553 0.9×	371 0.7×	117	3.3k
Kaitlyn Sadtler United States	20	1.2k 0.7×	343 0.5×	767 1.2×	826 1.3×	558 1.1×	40	3.0k
Kai Hu China	27	1.1k 0.7×	555 0.8×	701 1.1×	359 0.6×	135 0.3×	73	2.7k
Stefaan De Koker Belgium	36	1.9k 1.2×	307 0.4×	1.6k 2.6×	942 1.5×	1.0k 1.9×	73	4.5k
Jianfeng Han China	33	1.1k 0.7×	554 0.8×	707 1.1×	385 0.6×	415 0.8×	102	3.3k
Hong M. Moulton United States	43	4.1k 2.6×	985 1.4×	578 0.9×	254 0.4×	233 0.4×	83	5.5k
Sai T. Reddy Switzerland	37	2.7k 1.7×	482 0.7×	2.8k 4.4×	725 1.2×	403 0.8×	91	5.7k
Carsten Rudolph Germany	35	3.2k 2.0×	319 0.5×	406 0.6×	530 0.9×	548 1.0×	70	4.5k

Countries citing papers authored by Anna K. Blakney

Since Specialization

Citations

This map shows the geographic impact of Anna K. Blakney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna K. Blakney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna K. Blakney more than expected).

Fields of papers citing papers by Anna K. Blakney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna K. Blakney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna K. Blakney. The network helps show where Anna K. Blakney may publish in the future.

Co-authorship network of co-authors of Anna K. Blakney

This figure shows the co-authorship network connecting the top 25 collaborators of Anna K. Blakney. A scholar is included among the top collaborators of Anna K. Blakney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna K. Blakney. Anna K. Blakney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Varley, Andrew, Shigeki J. Miyake‐Stoner, Parinaz Aliahmad, et al.. (2025). Divergent Delivery and Expression Kinetics of Lipid and Polymeric Nanoparticles across mRNA Modalities. Advanced Science. 12(38). e08907–e08907.

Herrmann, Anna, Srinivas Abbina, Irina Chafeeva, et al.. (2024). An Ultrahydrating Polymer that Protects Protein Therapeutics and RNA‐Lipid Nanoparticles Against Freezing, Heat and Lyophilization Stress. Advanced Functional Materials. 34(42). 6 indexed citations

Chen, Yiyan, Xiaoyan Lin, Xuhan Liu, et al.. (2024). Thermally Robust Solvent-Free Liquid Polyplexes for Heat-Shock Protection and Long-Term Room Temperature Storage of Therapeutic Nucleic Acids. Biomacromolecules. 25(5). 2965–2972. 1 indexed citations

Blakney, Anna K., et al.. (2024). Exploring the Effects of Incorporating Different Bioactive Phospholipids into Messenger Ribonucleic Acid Lipid Nanoparticle (mRNA LNP) Formulations. SHILAP Revista de lepidopterología. 5(1). 154–165. 2 indexed citations

Blakney, Anna K., et al.. (2024). Trends in the synthetic polymer delivery of RNA. The Journal of Gene Medicine. 26(2). e3672–e3672. 9 indexed citations

Kitandwe, Paul Kato, Paul Rogers, Kai Hu, et al.. (2024). A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice. Vaccines. 12(10). 1088–1088. 2 indexed citations

Blakney, Anna K., et al.. (2023). A duplex droplet digital PCR assay for absolute quantification and characterization of long self-amplifying RNA. Scientific Reports. 13(1). 19050–19050. 3 indexed citations

Blakney, Anna K., et al.. (2023). Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics. Current Opinion in Biotechnology. 85. 103049–103049. 32 indexed citations

McKay, Paul F., Jie Zhou, Rebecca Frise, et al.. (2022). Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets. PubMed. 3(1). iqac004–iqac004. 8 indexed citations

10.

Spencer, Alexandra J., Paul F. McKay, Sandra Belij‐Rammerstorfer, et al.. (2021). Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice. Nature Communications. 12(1). 2893–2893. 87 indexed citations

11.

Blakney, Anna K., Yunqing Zhu, Paul F. McKay, et al.. (2020). Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer. ACS Nano. 14(5). 5711–5727. 128 indexed citations

12.

Gurnani, Pratik, Anna K. Blakney, Jonathan Yeow, et al.. (2020). An improved synthesis of poly(amidoamine)s for complexation with self-amplifying RNA and effective transfection. Polymer Chemistry. 11(36). 5861–5869. 11 indexed citations

13.

McKay, Paul F., Kai Hu, Anna K. Blakney, et al.. (2020). Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nature Communications. 11(1). 3523–3523. 339 indexed citations

14.

Blakney, Anna K., Paul F. McKay, Clément R. Bouton, et al.. (2020). Effect of complexing lipids on cellular uptake and expression of messenger RNA in human skin explants. Journal of Controlled Release. 330. 1250–1261. 34 indexed citations

15.

Blakney, Anna K., Paul F. McKay, Clément R. Bouton, et al.. (2020). Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA. Molecular Therapy. 29(3). 1174–1185. 66 indexed citations

16.

Blakney, Anna K., Yonghou Jiang, Dale Whittington, & Kim A. Woodrow. (2016). Simultaneous measurement of etravirine, maraviroc and raltegravir in pigtail macaque plasma, vaginal secretions and vaginal tissue using a LC–MS/MS assay. Journal of Chromatography B. 1025. 110–118. 12 indexed citations

17.

Blakney, Anna K., Felix I. Simonovsky, Ian T. Suydam, Buddy D. Ratner, & Kim A. Woodrow. (2016). Rapidly Biodegrading PLGA-Polyurethane Fibers for Sustained Release of Physicochemically Diverse Drugs. ACS Biomaterials Science & Engineering. 2(9). 1595–1607. 26 indexed citations

18.

Blakney, Anna K., et al.. (2014). Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures. International Journal of Nanomedicine. 9. 2967–2967. 66 indexed citations

19.

Barnes, Christopher A., et al.. (2014). Linking the foreign body response and protein adsorption to PEG-based hydrogels using proteomics. Biomaterials. 41. 26–36. 145 indexed citations

20.

Nelson, D., Ryotaro Hashizume, Tomo Yoshizumi, et al.. (2013). Intramyocardial Injection of a Synthetic Hydrogel with Delivery of bFGF and IGF1 in a Rat Model of Ischemic Cardiomyopathy. Biomacromolecules. 15(1). 1–11. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact